LINC00958 and acute myeloid leukemia: Out of these, ADARB2-AS1, LINC02600, AC120498.2, LINC01257 and LINC00958 had >10-fold increased expression in t(8;21) AML patients (Figure 1B) and interestingly, all have no known biological function in AML, with only LINC00958 having oncogenic roles reported in other solid malignancies [23,24,25].